© Copyright 2026, All Rights Reserved
Genomic analysis platform for Mycobacterium and SARS-CoV-2 with automated bioinformatics
Identify Mycobacterium species and drug resistance in clinical samples; Detect SARS-CoV-2 variants and related isolates from sequencing data; Enable real-time outbreak monitoring using genomic data; Support public health surveillance with automated pathogen tracking; Provide actionable insights for clinicians treating infectious diseases
Developed by University of Oxford's Modernising Medical Microbiology group; Partnered with Oracle for cloud infrastructure; Supports Illumina and Oxford Nanopore sequencing; Aligned to WHO V2 catalogue; Provides automated analysis with transformational speed in genomic workflows